U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836232) titled 'An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis' on Feb. 14.
Brief Summary: This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Recurrent Pericarditis (RP). Approximately 30 patients will take VTX2735.
The study consists of a 30-day Screening Period (to see if a participant qualifies for the study), a 6-week Open Label Treatment period (a participant receives active Dose A), a 7-week Extension Treatment period (a participant meets criteria for continuing and receives active Dose A) and a 14-day Follow-Up Period.
Study Start Date: Jan. 28
Study Type: INTERVENTIONAL
C...